【结 构 式】 |
【分子编号】39730 【品名】2,2-dihydroxyacetic acid 【CA登记号】 |
【 分 子 式 】C2H4O4 【 分 子 量 】92.05136 【元素组成】C 26.1% H 4.38% O 69.52% |
合成路线1
该中间体在本合成路线中的序号:(VIII)The condensation of 2-bromo-1-indanone (I) with 1-methylimidazole-2-carboxamide (II) in hot DMF produced the tetracyclic ammonium salt (III), which was further demethylated to (IV) by means of imidazole at 160 C. Regioselective nitration of (IV) employing KNO3 in H2SO4 produced nitro derivative (V), which was reduced to amine (VI) by catalytic hydrogenation over Pd/C. Amine (VI) was converted to urea (VII) by treatment with methyl isocyanate. Subsequent base-catalyzed condensation of (VII) with glyoxylic acid monohydrate (VIII) produced hydroxyacid (IX). This was dehydrated with ZnCl2 and acetic anhydride to give unsaturated acid (X), which was finally hydrogenated over Pd/C to furnish the title compound.
【1】 Genevois-Borella, A.; Aloup, J.-C.; Audiau, F.; Barreau, M.; Mignani, S.; Ribeill, Y.; Damour, D.; Jimonet, P. (Aventis Pharma SA); Imidazo (1,2-a)-indeno (1,2-e) pyrazin-4-one derivs. and pharmaceutical compsns. containing same. US 5807859; WO 9526350 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 39723 | 2-bromo-1-indanone | 1775-27-5 | C9H7BrO | 详情 | 详情 |
(II) | 39724 | 1-methyl-1H-imidazole-2-carboxamide | C5H7N3O | 详情 | 详情 | |
(III) | 39725 | 3-methyl-4-oxo-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-3-ium bromide | C14H12BrN3O | 详情 | 详情 | |
(IV) | 39726 | 5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one | C13H9N3O | 详情 | 详情 | |
(V) | 39727 | 8-nitro-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one | C13H8N4O3 | 详情 | 详情 | |
(VI) | 39728 | 8-amino-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one | C13H10N4O | 详情 | 详情 | |
(VII) | 39729 | N-methyl-N'-(4-oxo-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-8-yl)urea | C15H13N5O2 | 详情 | 详情 | |
(VIII) | 39730 | 2,2-dihydroxyacetic acid | C2H4O4 | 详情 | 详情 | |
(IX) | 39731 | 2-hydroxy-2-(8-[[(methylamino)carbonyl]amino]-4-oxo-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetic acid | C17H15N5O5 | 详情 | 详情 | |
(X) | 39732 | 2-(8-[[(methylamino)carbonyl]amino]-4-oxo-4,5-dihydro-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-ylidene)acetic acid | C17H13N5O4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VIII)In a related procedure, tetracyclic compound (IV) was first condensed with glyoxylic acid (VIII) giving hydroxyacid (XI), which was dehydrated to (XII) with ZnCl2 and Ac2O. Subsequent nitration of (XII) with KNO3 and H2SO4 afforded nitro derivative (XIII). Reduction of (XIII) with simultaneous esterification using iron and HCl in MeOH gave rise to amino ester (XIV). Urea (XV) was then obtained by condensation of (XIV) with methyl isocyanate. Finally, saponification of the ester group provided the title carboxylic acid.
【1】 Boireau, A.; Bohme, G.A.; Mignani, S.; et al.; 8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: Highly potent in vivo AMPA antagonists. Bioorg Med Chem Lett 2000, 10, 6, 591. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IV) | 39726 | 5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one | C13H9N3O | 详情 | 详情 | |
(VIII) | 39730 | 2,2-dihydroxyacetic acid | C2H4O4 | 详情 | 详情 | |
(XI) | 39733 | 2-hydroxy-2-(4-oxo-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetic acid | C15H11N3O4 | 详情 | 详情 | |
(XII) | 39734 | 2-(4-oxo-4,5-dihydro-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-ylidene)acetic acid | C15H9N3O3 | 详情 | 详情 | |
(XIII) | 39735 | 2-(8-nitro-4-oxo-4,5-dihydro-10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-ylidene)acetic acid | C15H8N4O5 | 详情 | 详情 | |
(XIV) | 39736 | methyl 2-(8-amino-4-oxo-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate | C16H14N4O3 | 详情 | 详情 | |
(XV) | 39737 | methyl 2-(8-[[(methylamino)carbonyl]amino]-4-oxo-5,10-dihydro-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate | C18H17N5O4 | 详情 | 详情 |